Canagliflozin and renal outcomes in type 2 diabetes: Results from the CANVAS program randomized clinical trials
Perkovic V et al. Lancet Diabetes Endocrinol 2018. doi: 10.1016/S2213-8587(18)30141-4
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.